期刊论文详细信息
Frontiers in Oncology | |
Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome | |
关键词: acute myeloid leukemia; myelodysplastic syndrome; measurable residual disease; hypomethylating agents; azacitidine; stem-cell transplant; | |
DOI : 10.3389/fonc.2020.576924 | |
来源: DOAJ |
【 授权许可】
Unknown